BRAINSTORM CELL THERAPEUTICS INC. - 10-Q filing on 2016-11-14

STOCK CAPITAL (Details Textual) - USD ($)																	1 Months Ended																															3 Months Ended		9 Months Ended		12 Months Ended		60 Months Ended	189 Months Ended
STOCK CAPITAL (Details Textual) - USD ($)	Jul. 14, 2016	Jan. 02, 2016	Nov. 10, 2015	Jun. 02, 2015	May 03, 2015	Jan. 08, 2015	Aug. 14, 2014	Jun. 13, 2014	Jun. 09, 2014	Jun. 06, 2014	Apr. 13, 2014	Nov. 13, 2013	Mar. 11, 2013	Feb. 07, 2013	Feb. 04, 2013	Aug. 01, 2012	Sep. 26, 2016	Sep. 22, 2016	Jun. 30, 2016	Jun. 21, 2016	Sep. 28, 2015	Aug. 27, 2015	Jul. 30, 2015	Apr. 29, 2015	Oct. 31, 2014	Aug. 15, 2014	Jul. 31, 2014	Jul. 28, 2014	May 27, 2014	Apr. 25, 2014	Mar. 24, 2014	Aug. 16, 2013	Apr. 30, 2013	Apr. 19, 2013	Jan. 16, 2013	Jul. 17, 2012	Jun. 30, 2012	Apr. 30, 2012	Aug. 22, 2011	Jun. 30, 2011	Dec. 16, 2010	Apr. 30, 2010	Feb. 28, 2010	Dec. 30, 2009	Jun. 30, 2008	Jul. 31, 2007	Nov. 25, 2004	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Jun. 30, 2016	Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from issuance of Common stock, net																																																		$ 0
Stock Issued During Period, Shares, Conversion of Convertible Securities																																												74,667
Proceeds From Issuance Or Sale Of Equity																																																$ 0	$ 0	0	$ 12,409,000				$ 46,600,000
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from issuance of Common stock, net																																																		2,496,000
Proceeds from Issuance of Warrants																																																		$ 829,000
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross																																																		14,246,831
Fair Value Assumptions, Weighted Average Volatility Rate																																																					140.00%
Fair Value Assumptions, Expected Dividend Rate																																																					0.00%
Legal Advisor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Based Compensation Recorded In General and Administrative Expenses													$ 44,500
Stock Issued During Period, Shares, Issued for Services		10,752											12,913															10,752
Stock Based Compensation Will Be Recorded In General And Administrative Expenses		$ 31,000																										$ 50,000
Scientific Advisory Board [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																										12 months
Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues																																			14,400
Stock Issued During Period, Shares, Issued for Services												30,000																			6,000
Stock Based Compensation Recorded In Research Development Expenses																																			$ 54,000
Service Provider [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Issued for Services													26,667
Stock Based Compensation Will Be Recorded In General And Administrative Expenses													$ 92,000
Placement Agent [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Investment Warrants, Exercise Price																																				$ 5.22
Warrants Issued To Placement Agent For Purchase Of Common Stock																																				32,931
Percentage Of Cash Fee On Gross Proceeds Of Offering																																				7.00%
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues																59,000																							61,558
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																12 months
Restricted Stock [Member] \| Scientific Advisory Board [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																																		12 months
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures																										50,667								50,667
Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Investment Warrants, Exercise Price																																																						$ 2.25
Investment Options, Exercise Price																$ 2.25									$ 0.75									$ 2.25							$ 2.25
Stock Option Expiration Term																																																						10 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	12 months																					12 months			12 months
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross	70,665															30,667						70,665			70,666									30,667							26,667													53,333
Shares Issued, Price Per Share	$ 0.75																					$ 0.75																	$ 15
Director [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues					60,000																	17,332
Director One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues																	8,666
Investment Options, Exercise Price				$ 0.75
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross				6,667
Director Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues																																																		8,666
Hadasit [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Issued To Purchase Of Common Stock																									8,889								2,222					2,222		2,222		2,222
Investment Warrants, Exercise Price																																	$ 0.00075					$ 0.00075		$ 0.00075		$ 0.00075
Hadasit [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Issued To Purchase Of Common Stock																																																				100,000
Investment Warrants, Exercise Price																																																				$ 0.015
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																																																				5 years
Mr. Israeli [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Investment Options, Exercise Price											$ 0.00075																						$ 0.00075					$ 0.00075		$ 0.00075		$ 0.00075
Number of options granted											20,000																						11,111					11,111		11,111		11,111
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross																									44,444
Chief Operating Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross										33,333
Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Grants In Period, Weighted Average Exercise Price										$ 2.70
Share Based Compensation Arrangement By Share Based Payment Award Unvested Portion to Purchase			253,333
Share Based Compensation Arrangement By Share Based Payment Award vested Portion Share			126,667
Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																					12 months
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross									380,000												369,619
Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Grants In Period, Weighted Average Exercise Price									$ 4.5
Shares Issued, Price Per Share																					$ 2.45
Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																							3 years
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross																							165,000
Shares Issued, Price Per Share																							$ 3.17
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights																							20,625 shares vested and became exercisable on July 30, 2016 and 2.08333% of the 82,500 shares were scheduled to vest and become exercisable on each monthly anniversary date starting on August 30, 2016 through the fourth anniversary of the grant, so that the 82,500 shares would become fully vested and exercisable on July 30, 2019.
Global Share Option Plan 2004 and U S Stock Option and Incentive Plan 2005 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Increase In Number Of Shares Available For Issuance																			1,600,000																		600,000			333,333					333,333
Shares Reserved For Issuance Under Stock Option Plan																																															609,564
Global Share Option Plan 2014 and U S Stock Option and Incentive Plan 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Increase In Number Of Shares Available For Issuance							600,000													1,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																				2,200,000																																				600,000
Investor [Member] \| Settlement Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities															8,408
Stock Issued During Period, Value, Conversion of Convertible Securities															$ 200,000
Holders of Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Issued To Purchase Of Common Stock																													333,235
Stock Repurchased During Period, Value																													$ 600,000
Warrants Repurchase Price																													$ 1.80
Maxim Group LLC [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Issued To Purchase Of Common Stock						38,000
Common Stock [Member] \| Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Issued for Services																		25,281						27,411
Stock Based Compensation Recorded In Research Development Expenses																								$ 108,000
Maximum [Member] \| Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair Value Assumptions, Risk Free Interest Rate																																																					3.14%
Fair Value Assumptions, Expected Term																																																					5 years 6 months
Maximum [Member] \| Warrant Issued One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair Value Assumptions, Expected Term																																																					9 years
Minimum [Member] \| Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair Value Assumptions, Risk Free Interest Rate																																																					2.39%
Fair Value Assumptions, Expected Term																																																					5 years
Minimum [Member] \| Warrant Issued One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair Value Assumptions, Expected Term																																																					1 year
Private Placement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues														55,556																													399,999
Proceeds from issuance of Common stock, net														$ 250,000																													$ 1,500,000
Warrants Issued To Purchase Of Common Stock																																											199,998
Investment Warrants, Exercise Price														$ 7.5																													$ 7.50
Deferred Compensation Arrangement with Individual, Maximum Contractual Term														32 months
Private Placement [Member] \| Investment Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues																																														2,777,777
Stock Issued During Period, Value, New Issues																																														$ 5,000,000
Private Placement [Member] \| Warrant Issued One [Member] \| Investment Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Issued To Purchase Of Common Stock																																														672,222
Investment Warrants, Exercise Price																																														$ 3
Private Placement [Member] \| Warrant Issued Two [Member] \| Investment Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Issued To Purchase Of Common Stock																																														1,344,444
Investment Warrants, Exercise Price																																														$ 4.35
Private Placement [Member] \| Unregistered Shares of Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from Issuance of Common Stock, Net						$ 12,400,000
Public Offering [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Converted																														777,471
Proceeds from Issuance of Common Stock, Net																																				$ 4,900,000
Public Offering [Member] \| Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues																																1,568,628				1,321,265
Proceeds from issuance of Common stock, net																																				$ 5,700,000
Common Stock Purchase Price																																$ 2.55
Warrants Issued To Purchase Of Common Stock																																1,176,471				990,949
Investment Warrants, Exercise Price																																$ 3.75				$ 4.35
Warrant Expiry Term																																3 years				30 months
Stock Issued During Period, Value, New Issues																																$ 4,000,000
Shares Issued, Price Per Share																																				$ 4.35
Proceeds from Issuance of Common Stock, Net																																$ 3,300,000
Public Offering [Member] \| Unregistered Shares of Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Converted																														388,735
Public Offering [Member] \| 2013 Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Investment Warrants, Exercise Price																											$ 0.525
Warrant Expiry Term								3 years
Investors Private Placement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues								2,800,000
Proceeds from issuance of Common stock, net								$ 10,500,000
Warrants Issued To Purchase Of Common Stock						2,546,667		2,800,000
Investment Warrants, Exercise Price						$ 5.22		$ 5.22
Warrant Expiry Term						warrants expire in June 2018
Shares Issued, Price Per Share								$ 3.75
Proceeds from Warrant Exercises						$ 13,300,000
Exercise Agreement, Fees and Expenses, Amount						$ 20,000
Investors Private Placement [Member] \| Maxim Group LLC [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Agreement, Maxim Cash Fee, Percentage						6.00%
Investors Private Placement [Member] \| Unregistered Shares of Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Issued To Purchase Of Common Stock						3,800,000
Investment Warrants, Exercise Price						$ 6.50